Nike is intentionally reducing sales volume of key products like the Dunk and Jordan lines, and pulling back from markets such as Greater China to restore brand exclusivity and pricing power. This strategy has led to a 4% revenue decline and a 5.8% drop in shares, with management expecting further revenue and profit declines into fiscal 2027 and possibly 2028. While performance sports segments grow, they are not yet large enough to offset declines in sportswear and key markets. Nike aims to improve revenue quality and build a sustainable foundation, but investors face uncertainty until clearer growth timelines are announced at an upcoming investor day.
Nike's strategy to cut sales volume and focus on brand prestige is mirrored in its current market performance. On Pluang, Nike's stock trades at USD 33.87, marking a 3.64% drop as of Oct 03, 2026, 19:01 WIB, near its 52-week low of USD 33.87. Despite this, the stock maintains a dividend yield of 4.84%, with a majority of Pluang users (63%) buying rather than selling, showing some investor confidence amid the company's challenges.
UBS has maintained a Neutral rating on Nike stock following the company's fiscal first-quarter revenue falling short of estimates and its announcement of layoffs. Nike's shares dropped over 7% amid weak earnings guidance and expectations of further s...
Nike's stock has dropped 75% over five years, pushing its dividend yield close to 5%, signaling market concerns. The company hopes to replicate Michael Jordan's past success by launching the Caitlin 1, its largest women's signature shoe, which sold o...
Nike shares fell below their 52-week low amid a shrinking sales outlook and challenges in China, with revenue expected to decline in fiscal 2027. Despite this, Piper Sandler analyst Abbie Zvejnieks rates Nike as Overweight with a $75 price target, im...
Nike's shares fell over 8% following a weaker-than-expected first-quarter revenue report, largely impacted by struggles in its China market. The company announced a restructuring plan that includes layoffs next year and forecasted a high-single-digit...
Nike reported a 4% decline in Q1 sales, driven by a 22% drop in China revenue, impacting its overall performance and leading to a 9% premarket share decline. Moderna will replace Warner Bros Discovery in the Nasdaq-100, reflecting its strong market p...
